vaccine against cd4 reactive t cells
Cell therapyexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started May 1, 2002 (NCT01448252)
Timeline
Indications
Mechanism of action
- Human immunodeficiency virus type I enhancer-binding protein 1Immunity, active
HIVEP1 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vaccine against cd4 reactive t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00407836 | Phase 2 | Nov 1, 2006 | Ben Gurion University, Technion University |
| NCT00228228 | Phase 3 | May 1, 2002 | Tel Aviv University |
| NCT01448252 | Phase 1/Phase 2 (Phase 2) | May 1, 2002 | Hebrew University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ben Gurion University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Hebrew University | Academic/Hospital | 1 | 1 | 1 | 2002 |
| Technion University | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Tel Aviv University | Academic/Hospital | 1 | 1 | 1 | 2002 |
4 organizations
Page 1 / 1